Insider Buying: agilon health, inc. (NYSE:AGL) CEO Purchases 20,000 Shares of Stock

agilon health, inc. (NYSE:AGL) CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

agilon health Stock Down 7.2 %

AGL traded down $0.25 on Monday, hitting $3.28. The company had a trading volume of 7,005,565 shares, compared to its average volume of 4,992,848. The stock has a market capitalization of $1.35 billion, a price-to-earnings ratio of -4.70 and a beta of 0.54. The stock has a fifty day moving average price of $5.39 and a 200-day moving average price of $5.60. agilon health, inc. has a 12-month low of $3.07 and a 12-month high of $20.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health’s revenue was up 38.7% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.04) EPS. Analysts predict that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on AGL shares. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Benchmark reiterated a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Truist Financial boosted their target price on agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a research report on Friday, May 24th. Finally, Robert W. Baird started coverage on shares of agilon health in a report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price target on the stock. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $8.57.

Institutional Trading of agilon health

A number of institutional investors have recently made changes to their positions in AGL. Capital International Investors grew its stake in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares during the last quarter. Capital World Investors grew its position in agilon health by 7.4% during the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock worth $692,992,000 after purchasing an additional 3,813,214 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after purchasing an additional 3,195,087 shares in the last quarter. Norges Bank purchased a new position in shares of agilon health in the fourth quarter worth $27,902,000. Finally, AQR Capital Management LLC lifted its stake in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.